Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
29.02.24
/
50%
€15.05
Target price
28.02.25
€20.28
Performance (%)
-73.24%
End price
01.03.25
€4.03
Summary
This prediction ended on 01.03.25 with a price of €4.03. Massive losses of -73.24% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has a follow-up prediction for Iovance Biotherapeutics Inc. where he still thinks Iovance Biotherapeutics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 13.340% | 13.340% | -66.564% |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at Barclays PLC from $18.00 to $22.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.00
14.04.25
14.04.25
€4.39
14.04.26
14.04.26
-20.11%
23.12.25
23.12.25
Stopped prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€2.40
24.12.25
24.12.25
€8.47
24.12.26
24.12.26
-
23.12.25
23.12.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
12.05.25
12.05.25
€3.56
12.05.26
12.05.26
46.65%
23.12.25
23.12.25